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In Sweden, falling rates of chlamydia, 2 pelvic inflammatory disease, 2 and ectopic pregnancy 3 have been attributed to intensive testing, treatment and partner notification to detect asymptomatic infections, in a variety of healthcare settings since the 1980s. In Britain, routine surveillance, testing and partner notification for chlamydia currently occur only in genitourinary clinics, although an expert advisory committee of the Chief Medical OYcer has now recommended targeted opportunistic screening in other health care settings. 4 We conducted ecological comparisons of the eVects of diVerent levels of chlamydia control on the incidence of one consequence, ectopic pregnancy, in SE Thames Region, England and Uppsala County, Sweden.
Methods
For SE Thames Region we obtained information from aggregated genitourinary clinic reports of chlamydia and from hospital episode statistics for ectopic pregnancy. For Uppsala, we used data from University Hospital, which deals with 99% of chlamydia specimens and all ectopic pregnancies in the County.
3 Ectopic pregnancy was recorded in both settings as International Classification of Diseases, 9th revision, XI.633.
Yearly chlamydia rates per 100 000 women and ectopic pregnancies per 1000 pregnancies (total of live births, induced abortions and ectopic pregnancies) for 15-34 year olds were calculated from 1988-1996. Direct standardisation was used to calculate age adjusted summary rates, using SE Thames census enumerated population in 1991 as the reference standard for chlamydia and, for ectopic pregnancy, the number of pregnancies in SE Thames residents in 1991.
2 Tests for trend were calculated for both conditions. Our analyses were restricted to women aged 15-34 years because, in this range, ectopic pregnancy rates are strongly correlated with rates of chlamydia diagnosed in the same year. [1988] [1989] [1990] [1991] [1992] [1993] [1994] [1995] [1996] , in SE Thames Region, 14 420 diagnoses of chlamydia and 536 854 pregnancies (5295 ectopic) in women aged 15-34 years were recorded. In Uppsala County there were 3739 episodes of chlamydia and 38 533 pregnancies (505 ectopic).
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Results
From
The respective 1991 populations were 558 460 and 39 923. Figure 1 shows that, over the study period, age adjusted rates of chlamydia cases per 100 000 women declined by 67%, from 1701 (95% confidence intervals 1574 to 1828) to 560 (490 to 630) in Uppsala and increased by 76%, from 245 (232 to 257) to 430 (412 to 448) in SE Thames. Rates of ectopic pregnancy per 1000 total pregnancies fell 56%, from 18 (14 to 22) to 8 (5 to 11) in Uppsala, and rose 39%, from 7 (6 to 8) to 10 (9 to 11) in SE Thames.
Comment
Intensive chlamydia control activities in Uppsala, Sweden are associated with marked falls in chlamydia and ectopic pregnancy rates in women under 35 years. During the same nine year period rates of both conditions rose in SE Thames Region.
Higher chlamydia rates in Uppsala are probably explained by widespread detection of asymptomatic cases, with only a quarter of specimens coming from genitourinary clinics.
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By 1996 however, the chlamydia rate in Uppsala, based on cases diagnosed in all settings was only 1.3 times higher than that in SE Thames, which only includes cases from genitourinary clinics. Reasons for the initial diVerence in ectopic pregnancy rates are less clear. The diagnosis of ectopic pregnancy is well defined but case reporting may be less accurate and complete in SE Thames. Extensive use of laparoscopy in Sweden, detecting some early ectopic pregnancies that would have aborted spontaneously, may exaggerate this disparity. The opposing direction of trends in the two countries is, however, more important than absolute rates for postulating the eVects of chlamydia control policies.
The decline in chlamydia rates in Uppsala is now slowing down, 5 so the achievable limit of the strategies adopted may have been reached. The recommendations of the Chief Medical OYcer's report 4 share features of the Swedish approach, but are less comprehensive. Opportunistic screening of sexually active women under 25 years and other selected groups is proposed, primarily in general practice and family planning clinics, with partner notification undertaken in genitourinary clinics. Policy makers in Britain should consider whether more comprehensive chlamydia control measures such as, the widespread use of improved diagnostic tests, partner notification in non-genitourinary settings, case finding in men and register-based screening are required.
Chlamydia surveillance should be extended to cases diagnosed in non-genitourinary settings and the value of ectopic pregnancy rates in women under 35 years as a marker of the eVectiveness of screening should be further investigated.
An earlier version of this paper was presented at the Medical Society for the Study of Venereal Diseases Spring Meeting, Oxford, 3-5 July 1997.
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